A PHASE 2 TRIAL OF COMBINED LUTETIUM PSMA THERANOSTICS AND DOCETAXEL IN NEWLY DIAGNOSED METASTATIC HORMONE NAIVE PROSTATE CANCER

$821,790FY2019Department of the ArmyDOD

University Of Melbourne, Melbourne

Investigators